We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$11.2M
2
XOM icon
ExxonMobil
XOM
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.8M
4
IBB icon
iShares Biotechnology ETF
IBB
+$10.2M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.12M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$265M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$98.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$32.7M
4
VNQ icon
Vanguard Real Estate ETF
VNQ
+$18.2M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.9M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SVA
2701
DELISTED
Sinovac Biotech, Ltd
SVA
$10K ﹤0.01%
1,607
-641
-29% -$3.85K
EVOL
2702
DELISTED
Evolving Systems, Inc.
EVOL
$10K ﹤0.01%
2,263
+1,086
+92% +$4.48K
CZR
2703
DELISTED
Caesars Entertainment Corporation
CZR
$10K ﹤0.01%
1,187
-3,885
-77% -$29.1K
ACV
2704
Virtus Diversified Income & Convertible Fund
ACV
$282M
$9K ﹤0.01%
+480
New +$8.78K
AMED
2705
DELISTED
Amedisys
AMED
$9K ﹤0.01%
208
-430
-67% -$18.3K
ASYS icon
2706
Amtech Systems
ASYS
$272M
$9K ﹤0.01%
2,008
+500
+33% +$2.27K
AVGO icon
2707
Broadcom
AVGO
$2.04T
$9K ﹤0.01%
+510
New +$8.84K
CPRX
2708
DELISTED
Catalyst Pharmaceutical
CPRX
$9K ﹤0.01%
8,097
+387
+5% +$442
CRWS icon
2709
Crown Crafts
CRWS
$32.3M
$9K ﹤0.01%
1,127
+724
+180% +$6.49K
CYBR
2710
DELISTED
CyberArk
CYBR
$9K ﹤0.01%
200
+161
+413% +$7.85K
DCOM icon
2711
Dime Commercial Bancshares
DCOM
$1.78B
$9K ﹤0.01%
+236
New +$7.53K
DGII icon
2712
Digi International
DGII
$3.1B
$9K ﹤0.01%
+669
New +$8.2K
DWSN icon
2713
Dawson Geophysical
DWSN
$135M
$9K ﹤0.01%
+1,197
New +$8.62K
FEIM icon
2714
Frequency Electronics
FEIM
$816M
$9K ﹤0.01%
834
+734
+734% +$7.37K
GNE icon
2715
Genie Energy
GNE
$383M
$9K ﹤0.01%
1,536
+1,436
+1,436% +$8.31K
JACK icon
2716
Jack in the Box
JACK
$335M
$9K ﹤0.01%
77
-534
-87% -$54.5K
LILA icon
2717
Liberty Latin America Class A
LILA
$1.67B
$9K ﹤0.01%
625
-156
-20% -$2.37K
MEDP icon
2718
Medpace
MEDP
$16.5B
$9K ﹤0.01%
227
-2,410
-91% -$80.3K
MLAB icon
2719
Mesa Laboratories
MLAB
$574M
$9K ﹤0.01%
73
-10
-12% -$1.25K
NOM
2720
DELISTED
Nuveen Missouri Quality Municipal Income Fund
NOM
$9K ﹤0.01%
600
-174
-22% -$2.86K
OSUR icon
2721
OraSure Technologies
OSUR
$279M
$9K ﹤0.01%
+1,095
New +$9.04K
OVV icon
2722
Ovintiv
OVV
$16.4B
$9K ﹤0.01%
117
-3,648
-97% -$208K
PKOH icon
2723
Park-Ohio Holdings
PKOH
$761M
$9K ﹤0.01%
212
+112
+112% +$4.3K
PPH icon
2724
VanEck Pharmaceutical ETF
PPH
$938M
$9K ﹤0.01%
167
-275
-62% -$14.7K
RNAC icon
2725
Cartesian Therapeutics
RNAC
$268M
$9K ﹤0.01%
18
+4
+29% +$2.34K
107 108
109
110 111

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.